BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 30989663)

  • 1. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3β and stabilizing β-catenin.
    Zhang CH; Liu H; Zhao WL; Zhao WX; Zhou HM; Shao RG
    Acta Pharmacol Sin; 2021 Nov; 42(11):1900-1912. PubMed ID: 33536604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
    Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
    Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
    Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of G3BP1 facilitates the progression of colon cancer by activating β‑catenin signaling.
    Li Y; Wang J; Zhong S; Li J; Du W
    Mol Med Rep; 2020 Nov; 22(5):4403-4411. PubMed ID: 33000280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles and mechanisms of G3BP1 in tumour promotion.
    Zhang CH; Wang JX; Cai ML; Shao R; Liu H; Zhao WL
    J Drug Target; 2019 Mar; 27(3):300-305. PubMed ID: 30207743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.
    Ramachandran B; Stabley JN; Cheng SL; Behrmann AS; Gay A; Li L; Mead M; Kozlitina J; Lemoff A; Mirzaei H; Chen Z; Towler DA
    J Biol Chem; 2018 May; 293(21):7942-7968. PubMed ID: 29626090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).
    Li M; Tang Y; Zuo X; Meng S; Yi P
    Bioengineered; 2022 Jan; 13(1):721-734. PubMed ID: 34967276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
    Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
    Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone inhibits the proliferation and invasion of esophageal cancer cells by disrupting the AKT/GSK-3β/Wnt signaling pathway via PTEN upregulation.
    Ma J; Zhang Y; Deng H; Liu Y; Lei X; He P; Dong W
    Phytother Res; 2020 Dec; 34(12):3388-3399. PubMed ID: 32901987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
    Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
    Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
    Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
    Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling.
    Tantai JC; Zhang Y; Zhao H
    Mol Med Rep; 2016 Feb; 13(2):1097-104. PubMed ID: 26647768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways.
    Liu S; Chen L; Chen H; Xu K; Peng X; Zhang M
    J Exp Clin Cancer Res; 2021 Feb; 40(1):66. PubMed ID: 33579337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/β-Catenin Signalings.
    Chen Y; Ma Q; Sun N
    Ann Clin Lab Sci; 2023 Mar; 53(2):271-277. PubMed ID: 37094865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.